https://www.selleckchem.com/pr....oducts/o6-benzylguan
demonstrate more frequent active disease or IBD-associated complications, suggesting that other nonluminal factors influence their symptoms and/or decision to use cannabis. These findings demonstrate the importance of evaluating for extraintestinal contributors to symptom burden in IBD cannabis users, as well as the ongoing need to develop safer and more effective methods for recognizing and managing abdominal pain and other symptoms in this setting.Background and Objectives Preclinical studies have shown cannabidiol is protect
Мне нравится
Комментарий
Перепост
